NHI National Health Investors Inc

Price (delayed)

$65.14

Market cap

$2.99B

P/E Ratio

18.35

Dividend/share

$4.41

EPS

$3.55

Enterprise value

$4.4B

Highlights
NHI's equity is up by 3.8% YoY and by 2.6% from the previous quarter
NHI's P/E is 13% more than its last 4 quarters average of 16.3 but 2.4% less than its 5-year quarterly average of 18.8
National Health Investors's EPS has decreased by 16% YoY and by 14% QoQ
The net income is down by 14% year-on-year and by 14% since the previous quarter

Key stats

What are the main financial stats of NHI
Market
Shares outstanding
45.85M
Market cap
$2.99B
Enterprise value
$4.4B
Valuations
Price to earnings (P/E)
18.35
Price to book (P/B)
1.9
Price to sales (P/S)
8.93
EV/EBIT
20.83
EV/EBITDA
14.93
EV/Sales
13.3
Earnings
Revenue
$330.6M
EBIT
$211.15M
EBITDA
$294.66M
Free cash flow
$197.2M
Per share
EPS
$3.55
Free cash flow per share
$4.35
Book value per share
$34.35
Revenue per share
$7.3
TBVPS
$70.26
Balance sheet
Total assets
$3.18B
Total liabilities
$1.62B
Debt
$1.52B
Equity
$1.55B
Working capital
N/A
Liquidity
Debt to equity
0.98
Current ratio
N/A
Quick ratio
N/A
Net debt/EBITDA
4.79
Margins
EBITDA margin
89.1%
Gross margin
100%
Net margin
48.2%
Operating margin
66.5%
Efficiency
Return on assets
5.1%
Return on equity
10.5%
Return on invested capital
4.6%
Return on capital employed
N/A
Return on sales
63.9%
Dividend
Dividend yield
6.77%
DPS
$4.41
Payout ratio
124.3%

NHI stock price

How has the National Health Investors stock price performed over time
Intraday
-0.73%
1 week
-2.06%
1 month
-2.63%
1 year
2.71%
YTD
-5.83%
QTD
-9.88%

Financial performance

How have National Health Investors's revenue and profit performed over time
Revenue
$330.6M
Gross profit
$330.6M
Operating income
$219.9M
Net income
$159.44M
Gross margin
100%
Net margin
48.2%
The net margin has declined by 16% year-on-year and by 13% since the previous quarter
The net income is down by 14% year-on-year and by 14% since the previous quarter
The operating margin has contracted by 4.2% YoY
The operating income is down by 2.5% year-on-year and by 2.2% since the previous quarter

Growth

What is National Health Investors's growth rate over time

Valuation

What is National Health Investors stock price valuation
P/E
18.35
P/B
1.9
P/S
8.93
EV/EBIT
20.83
EV/EBITDA
14.93
EV/Sales
13.3
National Health Investors's EPS has decreased by 16% YoY and by 14% QoQ
NHI's P/E is 13% more than its last 4 quarters average of 16.3 but 2.4% less than its 5-year quarterly average of 18.8
NHI's price to book (P/B) is 14% less than its 5-year quarterly average of 2.2
NHI's equity is up by 3.8% YoY and by 2.6% from the previous quarter
The stock's P/S is 16% less than its 5-year quarterly average of 10.6

Efficiency

How efficient is National Health Investors business performance
The ROE has contracted by 17% YoY and by 15% from the previous quarter
The return on assets has declined by 16% year-on-year and by 14% since the previous quarter
The ROIC has declined by 15% year-on-year and by 10% since the previous quarter
National Health Investors's return on sales has decreased by 14% YoY and by 11% QoQ

Dividends

What is NHI's dividend history
DPS
$4.41
Dividend yield
6.77%
Payout ratio
124.3%
Recent dividends

Financial health

How did National Health Investors financials performed over time
The total assets is 96% more than the total liabilities
The total liabilities has contracted by 2.4% YoY
The total assets has grown by 2% from the previous quarter
The debt to equity has contracted by 6% YoY
NHI's equity is up by 3.8% YoY and by 2.6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.